Related Experiment Video

Updated: Sep 1, 2025

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

61.4K

Timing is everything: Clinical evidence supports pre-symptomatic treatment for spinal muscular atrophy

Anna A L Motyl1, Thomas H Gillingwater1

  • 1Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK; Euan MacDonald Centre for Motor Neuron Disease, University of Edinburgh, Edinburgh, UK.

Cell Reports. Medicine
|August 17, 2022
PubMed

Insights

Gene therapy is safe and effective for children with spinal muscular atrophy (SMA) when given before symptoms appear. Early treatment through newborn screening offers the best outcomes for SMA patients.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Spinal muscular atrophy (SMA) is a severe genetic disorder affecting motor neurons.
  • Early intervention is crucial for improving outcomes in SMA patients.

Purpose of the Study:

  • To evaluate the safety and efficacy of pre-symptomatic gene therapy in infants with SMA.
  • To assess the impact of early gene therapy on disease progression.

Main Methods:

  • Two new studies investigated gene therapy delivery in pediatric SMA cases.
  • The studies focused on pre-symptomatic treatment administration.

Main Results:

  • Pre-symptomatic gene therapy demonstrated a safe and effective profile in children with SMA.
  • Early intervention led to positive clinical outcomes, preventing symptom onset.

Conclusions:

  • Newborn screening programs are vital for identifying SMA cases early.
  • Timely gene therapy delivery before symptom onset significantly improves prognosis for children with SMA.

More Related Videos

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.8K
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

13.7K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K